Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026)
Elanco Animal Health (ELAN) reported Total Current Liabilities of $1.7 billion for Q1 2026, up 30.97% on a YoY basis from $1.3 billion in Q1 2025, and up 4.07% sequentially from $1.6 billion in Q4 2025.
Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Total Current Liabilities data on file, last reported at $1.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 30.97% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 30.97% YoY), and the FY2025 full-year result was $1.6 billion, up 21.44% from the prior year.
- Total Current Liabilities grew to $1.7 billion in Q1 2026, from $1.6 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.7 billion in Q4 2022 to a low of $1.2 billion in Q1 2024.
- A 5-year average of $1.4 billion and a median of $1.3 billion in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities slumped 35.74% in 2022 and jumped 30.97% in 2026, its largest moves.
- Tracing ELAN's Total Current Liabilities over 5 years: stood at $1.7 billion in 2022, then fell by 27.09% to $1.2 billion in 2023, then rose by 5.96% to $1.3 billion in 2024, then climbed by 21.44% to $1.6 billion in 2025, then rose by 4.07% to $1.7 billion in 2026.
- Business Quant data shows ELAN's Total Current Liabilities at $1.7 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 215.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.60 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.32 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.58 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.36 Bn |
| Jun 30, 2021 | 1.99 Bn |